Article
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients.
Journal of affective disorders - 1 Dec 2009
Mandelli Laura, Mazza Marianna, Martinotti Giovanni, Di Nicola Marco, Tavian Daniela, Colombo Elisa, Missaglia Sara, De Ronchi Diana, Colombo Roberto, Janiri Luigi, Serretti Alessandro
Abstract excerpt
Response to pharmacological treatments is moderated by both genetic and environmental factors. The contribution of such factors is relatively small and complex interactions are likely to be involved. Serotonin transporter gene (SLC6A4) is a major candidate gene associated to response to antidepre...
Topics
- Adult
- Antidepressive Agents
- Bipolar Disorder
- Female
- Genetic Variation
- Genotype
- Harm Reduction
- Humans
- Male
- Middle Aged
- Serotonin Plasma Membrane Transport Proteins
- Treatment Outcome
